CSBR Short Volume
Champions Oncology, Inc. (CSBR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $73.6M, listed on NASDAQ, employing roughly 214 people, carrying a beta of 0.40 to the broader market. Champions Oncology, Inc. Led by Robert Brainin, public since 2007-02-02.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-09-22
- Short Volume
- 132
- Total Volume
- 5.8K
- Short %
- 2.28%
- 30-Day Avg Short %
- 34.75%
Showing 30 days of FINRA short volume data for Champions Oncology, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked CSBR short volume questions
- What is the daily CSBR short volume?
- As of Sep 22, 2026, Champions Oncology, Inc. (CSBR) short volume is 132 shares against 5.8K total reported volume, or 2.28% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CSBR short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CSBR short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.